SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-023040
Filing Date
2023-08-10
Accepted
2023-08-10 16:11:46
Documents
15
Period of Report
2023-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pbla20230809_8k.htm   iXBRL 8-K 28322
2 EXHIBIT 99.1 ex_558060.htm EX-99.1 173121
7 ex_558060img001.jpg GRAPHIC 5280
  Complete submission text file 0001437749-23-023040.txt   357501

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pbla-20230810.xsd EX-101.SCH 3408
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbla-20230810_def.xml EX-101.DEF 11423
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbla-20230810_lab.xml EX-101.LAB 15309
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbla-20230810_pre.xml EX-101.PRE 11583
9 EXTRACTED XBRL INSTANCE DOCUMENT pbla20230809_8k_htm.xml XML 2551
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39468 | Film No.: 231159482
SIC: 2834 Pharmaceutical Preparations